€15 million for the growth and internationalisation of Svas Biosana, the main Italian operator in the medical devices, medical equipment and injectable drugs market.
The CDP Group is supporting this Campania based company with the ELITE Basket Bond and Export Basket Bond. In December 2017, the company received an initial loan of €10 million to grow and consolidate its Italian market leadership. In April 2019, Svas Biosana benefited from an additional €5 million to develop its business on international markets.
With an annual turnover of almost €100 million, which has doubled in the last 10 years, and around 500 employees, Svas Biosana has based its development strategy both on the growth of internal lines, with a wide and diversified product portfolio, and external lines, through acquisitions that have proven fundamental for the Company's development.
The Group, based in Somma Vesuviana (Naples), manages more than 10 thousand products under its own brand and third party brands and controls 9 companies in Italy, Slovenia, Croatia, Bosnia Herzegovina and Serbia, with 4 production sites and 7 distribution centres.
The Group is an important part of the industrial heritage of Southern Italy and operates in the highly competitive medical sector, making substantial investments in R&D. Its expansion on the European market, and in particular in the Balkans, has resulted in the remarkable growth of this example of the excellence of Made in Italy.
The CDP Group plays an important role in supporting the development of Italian companies, with increasingly flexible and innovative instruments, to encourage exports and the internationalisation of our industrial system.